← Back

Santé Ventures Fund 5

vc$330M

Fund Size

$330M

Check Size

$5.0M$20.0M

Location

United States

Activity

Statusactively investing

Links

Share this fund

Investment Thesis

Focus on early-stage prospects, breakthrough healthcare innovation, and understanding of biology to move the needle from a patient perspective.

About Santé Ventures

Santé Ventures is an Austin-based healthcare and life sciences investor focused on early-stage companies in biotech, medtech, and healthtech. The firm emphasizes thematic investing, rigorous scientific diligence, and hands-on company creation, with an interest in companies that address clinical complexity, capital inefficiency, or outdated care delivery models.[1][5]

Sectors

BiotechDrug DiscoveryMedtechDigital HealthDiagnostics

Stages

seedseries-a

Geography Focus

United States

Team

NameTitleRoleLinks
Casey CunninghamPartner and Chief Scientific Officerin
Eric EpsteinPartnerin
Louis BockVenture Partnerin

Notable Investments

Reprieve CardiovascularGeneos TherapeuticsFarapulseClaret MedicalTVA Medical

FAQ

What does Santé Ventures Fund 5 invest in?

Santé Ventures Fund 5 invests in Biotech, Drug Discovery, Medtech, Digital Health and Diagnostics at the seed and series-a stages.

Which geographies does Santé Ventures Fund 5 focus on?

Santé Ventures Fund 5 focuses on United States, and is headquartered in United States.

What is Santé Ventures Fund 5's typical check size?

Santé Ventures Fund 5 typically writes checks of $5M to $20M.